Gritstone bio, Inc.

NasdaqGS:GRTS 株式レポート

時価総額:US$22.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Gritstone bio マネジメント

マネジメント 基準チェック /24

Gritstone bio'sの CEO はAndrew Allenで、 Aug2015年に任命され、 の在任期間は 9.08年です。 の年間総報酬は$ 3.44Mで、 18.8%給与と81.2%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の1.53%を直接所有しており、その価値は$ 863.78K 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と6.7年です。

主要情報

Andrew Allen

最高経営責任者

US$3.4m

報酬総額

CEO給与比率18.8%
CEO在任期間9.2yrs
CEOの所有権1.5%
経営陣の平均在職期間3.6yrs
取締役会の平均在任期間6.4yrs

経営陣の近況

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Recent updates

We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Jun 11
We Think Some Shareholders May Hesitate To Increase Gritstone bio, Inc.'s (NASDAQ:GRTS) CEO Compensation

Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering

Apr 07

Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Aug 14
Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%

Gritstone bio: Early Data For SLATE Candidate Sets Up 2023 Catalyst

Sep 26

Gritstone reaches six-month high on publication of data for cancer vaccine

Aug 16

Gritstone bio announces $80M credit facility

Jul 21

Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Jul 07
Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?

Gritstone bio: Potential To Advance Colorectal Cancer Treatment

Jul 05

Gritstone bio: Investing In A Premium mRNA Technology At A Discounted Valuation

Jun 14

Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

Mar 17
Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates

We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Mar 05
We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate

Gritstone: Why The Stock Fell On Positive Data

Jan 18

Gritstone bio (NASDAQ:GRTS) Is In A Strong Position To Grow Its Business

Nov 23
Gritstone bio (NASDAQ:GRTS) Is In A Strong Position To Grow Its Business

Gritstone Poised To Dominate mRNA Market

Nov 08

CEO報酬分析

Gritstone bio の収益と比較して、Andrew Allen の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$133m

Mar 31 2024n/an/a

-US$145m

Dec 31 2023US$3mUS$646k

-US$138m

Sep 30 2023n/an/a

-US$139m

Jun 30 2023n/an/a

-US$130m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$3mUS$620k

-US$120m

Sep 30 2022n/an/a

-US$118m

Jun 30 2022n/an/a

-US$116m

Mar 31 2022n/an/a

-US$112m

Dec 31 2021US$4mUS$589k

-US$75m

Sep 30 2021n/an/a

-US$72m

Jun 30 2021n/an/a

-US$70m

Mar 31 2021n/an/a

-US$71m

Dec 31 2020US$2mUS$569k

-US$105m

Sep 30 2020n/an/a

-US$106m

Jun 30 2020n/an/a

-US$107m

Mar 31 2020n/an/a

-US$103m

Dec 31 2019US$2mUS$533k

-US$94m

Sep 30 2019n/an/a

-US$84m

Jun 30 2019n/an/a

-US$75m

Mar 31 2019n/an/a

-US$69m

Dec 31 2018US$2mUS$475k

-US$65m

Sep 30 2018n/an/a

-US$65m

Jun 30 2018n/an/a

-US$56m

Mar 31 2018n/an/a

-US$47m

Dec 31 2017US$592kUS$436k

-US$41m

報酬と市場: Andrewの 総報酬 ($USD 3.44M ) は、 US市場 ($USD 680.04K ) の同規模の企業の平均を上回っています。

報酬と収益: Andrewの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Andrew Allen (58 yo)

9.2yrs

在職期間

US$3,444,071

報酬

Dr. Andrew R. Allen, BM, BCh, MA, MRCP, M.D., Ph D., serves as Independent Director at Verge Analytics, Inc. since September 2021. He has also held clinical development leadership positions at Chiron Corpo...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Andrew Allen
Co-Founder9.2yrsUS$3.44m1.53%
$ 344.2k
Erin Jones
Executive VP & COO3.6yrsUS$1.52m0.063%
$ 14.2k
Karin Jooss
Executive VP and Head of Research & Development3.6yrsUS$1.58m0.39%
$ 87.6k
Vassiliki Economides
Executive VP & CFO3.3yrsデータなし0.059%
$ 13.2k
James Cho
Chief Accounting Officer3.8yrsデータなし0.070%
$ 15.7k
George MacDougall
Director of Investor Relations & Corporate Communicationsno dataデータなしデータなし
Stacy Proctor
Executive VP & Chief People Officer3.3yrsデータなしデータなし
Matthew Hawryluk
Executive VP & Chief Business Officer8.9yrsデータなし0.034%
$ 7.6k

3.6yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: GRTSの経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Andrew Allen
Co-Founder9.2yrsUS$3.44m1.53%
$ 344.2k
Elaine Jones
Independent Chairman of the Board5.1yrsUS$176.00k0%
$ 0
Stephen Webster
Independent Directorless than a yearデータなし0.021%
$ 4.8k
Lawrence Corey
Independent Director2.2yrsUS$132.50k0%
$ 0
Timothy Chan
Member of Scientific Advisory Board7.3yrsデータなしデータなし
Eugene Zhukovsky
Member of Scientific Advisory Board5.5yrsデータなし0%
$ 0
Graham Lord
Member of Scientific Advisory Board7.3yrsデータなしデータなし
Naiyer Rizvi
Independent Director & Member of Scientific Advisory Board8.3yrsUS$140.00k0%
$ 0
James Gulley
Member of Scientific Advisory Board7.3yrsデータなしデータなし
Alessandro Sette
Member of Scientific Advisory Board7.3yrsデータなしデータなし
Shefali Agarwal
Independent Director3.3yrsUS$138.50k0%
$ 0
Clare Fisher
Independent Director2.8yrsUS$136.50kデータなし

6.4yrs

平均在職期間

61.5yo

平均年齢

経験豊富なボード: GRTSの 取締役会経験豊富 であると考えられます ( 6.6年の平均在任期間)。